NFKB1 and cardiac hypertrophy: We further show that ATF3 overexpression leads to a decreased rate of protein synthesis, a marker for cardiac hypertrophy, and is characterized with activation of a suppressor of inflammation, NF-κB, as well as with activation of a survival factor Nkx-2.5.